Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes

Sylvia K Shenouda1, Kurt J Varner, Felix Carvalho

  • 1Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112, USA.

Insights

3,4-methylenedioxymethamphetamine (MDMA) metabolites, not MDMA itself, cause oxidative stress and impair heart cell function. N-acetyl-cysteine (NAC) protected against these harmful effects, suggesting a metabolic pathway for MDMA cardiotoxicity.

Area of Science:

  • Cardiology
  • Toxicology
  • Biochemistry

Background:

  • Repeated 3,4-methylenedioxymethamphetamine (MDMA) use leads to left ventricular dilation and diastolic dysfunction.
  • The precise mechanisms behind MDMA cardiotoxicity remain unclear, but oxidative stress is implicated.
  • MDMA metabolism generates reactive intermediates contributing to oxidative stress.

Purpose of the Study:

  • To investigate whether MDMA metabolites induce oxidative stress and contractile dysfunction in adult rat ventricular myocytes.
  • To identify specific MDMA metabolites responsible for cardiac toxicity.
  • To evaluate the protective effects of N-acetyl-cysteine (NAC) against MDMA metabolite-induced damage.

Main Methods:

  • Isolated adult rat left ventricular myocytes were treated with MDMA and its metabolites.
  • Reactive oxygen species (ROS) production was measured using dihydroethidium.
  • Myocyte contractility and intracellular calcium transients were assessed using the IonOptix system.
  • The effects of N-acetyl-cysteine (NAC) were evaluated.

Main Results:

  • MDMA treatment alone did not increase ROS production in myocytes.
  • Three specific MDMA metabolites (alpha-methyl dopamine, N-methyl alpha-methyl dopamine, and 2,5-bis(glutathion-S-yl)-alpha-MeDA) induced time- and concentration-dependent increases in ROS.
  • These metabolites, but not MDMA, significantly impaired myocyte contractility and relaxation.
  • NAC administration prevented both the ROS production and the contractile dysfunction induced by the metabolites.

Conclusions:

  • MDMA-induced oxidative stress and cardiotoxicity in the left ventricle are, at least partly, mediated by its redox-active metabolites.
  • Targeting these metabolic pathways may offer therapeutic strategies for mitigating MDMA-related cardiac damage.
  • The findings highlight the importance of understanding drug metabolism in predicting and preventing toxicity.

Related Concept Videos